GCP and Regulatory Guidelines on Re-Consent in Clinical Trials
GCP and Regulatory Guidelines on Re-Consent in Clinical Trials Understanding GCP and Regulatory Requirements for Re-Consent in Clinical Trials Re-consent is a crucial component of ethical clinical trial conduct, ensuring that participants remain fully informed throughout their trial journey. As per global Good Clinical Practice (GCP) standards and local regulatory authorities like USFDA and CDSCO,…
Read More “GCP and Regulatory Guidelines on Re-Consent in Clinical Trials” »